Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1fdc7f4c8e564cf2e5d4960f084af4b2 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-8128 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-36 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-81 |
filingDate |
2008-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe7425aada49d9fdb213e5664bae90cd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15d869b052290fe6c79503161128ebcd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d69cfb043902056a6209774f091c65bf |
publicationDate |
2010-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2175877-A1 |
titleOfInvention |
Use of mutated antithrombins for treating or preventing coagulation disorders |
abstract |
Use of a mutated antithrombin having substantially no activity,in particular no anticoagulant activity, possibly in association with an anticoagulant, for the preparation of a drug intended for the prevention or treatment of pathologies linked to or associated with coagulation disorders. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10351619-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9982035-B2 |
priorityDate |
2007-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |